Singapore, April 13 -- Australia-based Telix Pharmaceuticals and US-based Regeneron Pharmaceuticals, Inc. have announced a collaboration to jointly develop and commercialise next generation radiopharmaceutical therapies.
Published by HT Digital Content Services with permission from BioSpectrum Asia....
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.
